W.H.O. Europe pushes cancer warnings on every alcoholic drink

The World Health Organization’s Europe office is pressing for cancer warnings on all alcoholic drinks, including beer, as governments and producers weigh whether the labels are a public health tool or a step meant to discourage drinking more broadly.

The push follows the agency’s 2023 statement that there is no safe level of alcohol consumption. WHO Europe said cancer warnings are needed because many consumers remain unaware of the link between alcohol and cancer. Its regional director, Dr. Hans Henri Kluge, said labels would give people information to make informed choices.

The debate has moved from public health circles into trade and regulation, with Ireland at the center. Under its Public Health (Alcohol) Act 2018, Ireland had been set to become the first Western country this May to require all alcoholic drinks to carry cancer warnings. Instead, the measure was delayed until September 2028.

That postponement has left producers, importers and retailers in limbo. Ignacio Sanchez Recarte, secretary-general of the Comité Européen des Entreprises Vins, said the delay still leaves little time for companies whose products move slowly through supply chains. “2028 is tomorrow,” he said, adding that some importers and retailers are already asking companies not to apply the label.

For brewers and other drinks companies, the issue carries clear regulatory risk. If national rules begin to diverge, businesses could face new packaging requirements, compliance costs and market-by-market decisions on labeling, especially for products sold across borders.

Supporters of stricter labels say alcohol policy should follow the path taken with tobacco. Dr. Sheila Gilheany of Alcohol Action Ireland said Ireland should lead on alcohol labeling as it once did on smoking restrictions, arguing that other countries are watching closely and could follow.

Industry groups and some researchers question both the purpose and likely effect of the warnings. Dr. Creina Stockley, co-director of the International Scientific Forum on Alcohol Research, said a central question is whether labels are mainly intended to inform consumers or to frighten them into drinking less. She said that if the goal is informed choice, modest labels may be enough, but if the goal is lower consumption, policymakers may push over time for larger and more graphic warnings, as happened with tobacco.

Cancer warnings on alcohol are relatively new. South Korea introduced a cancer-related alcohol warning in 2016. In Canada, researchers led by Professor Tim Stockwell tested bright warning labels in Yukon in 2017 that said alcohol can cause cancer. Stockwell later said the trial reduced sales by more than 6%, though drinks companies challenged both the design and the process after saying they had not been consulted. A bill that would require such labels nationally remains before the Canadian Senate, although Professor Dan Malleck of Brock University said he did not expect it to pass.

The Irish case has also raised trade concerns. A senior industry source said U.S. officials viewed the proposed labeling rule as a non-tariff barrier and warned of retaliation against any country that adopted it. That concern has fed hopes among parts of the industry that Dublin may ultimately seek an EU-wide approach instead of acting alone.

Such a move would open another political battle inside Europe. Large wine-producing countries such as Italy are widely seen by industry participants as unlikely to support mandatory cancer wording at the bloc level. Gilheany rejected waiting for Brussels, saying Ireland should move ahead on its own.

For now, there is no European consensus. Recarte said some policymakers have told producers not to worry because they believe the Irish plan will never take effect. But he also said that if separate national laws start appearing across Europe, companies may end up asking the European Union to harmonize the rules.

The broader dispute goes beyond one label. It reflects a larger shift in alcohol policy since smoking controls became firmly established in many countries. Public health advocates increasingly argue that alcohol should be treated with similar urgency because of its cancer link, while producers warn that labeling mandates can become a blunt regulatory tool with commercial consequences across beer, wine and spirits.